All In Biotech

Drug Trial Radar · NCT02566369

Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris

A Multi-Center, Randomized, Double-Blind, Parallel-Group Vehicle Controlled Study To Compare The Efficacy And Safety Of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream In Subjects With Acne Vulgaris

Last checked: Nov 19, 2026Latest source record: Nov 12, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,208 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,208

Actual

Start

Nov 30, 2015

Primary completion

Nov 14, 2017

Study completion Nov 14, 2017

Sponsor

Lead sponsor
Galderma R&DIndustry
Sponsor type
Industry
First posted
Oct 2, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 9 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Assessment of the efficacy and safety of CD5789 (trifarotene) 50μg/g cream applied once daily for 12 weeks in subjects with acne vulgaris.

Conditions

  • Acne Vulgaris

Interventions

  • CD5789 (trifarotene) 50μg/g creamDrug

    CD5789 (trifarotene) 50µg/g cream applied once daily for 12 weeks.

  • Placebo creamDrug

    Placebo cream applied once daily for 12 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Investigator Global Assessment (IGA) Success Rate at Week 12Time frame: From Baseline to Week 12

Locations

124 sites in 5 countries. Site status is shown where the registry gives one.

  • Galderma Investigational Site (8258)

    Mobile, Alabama

  • Galderma Investigational Site (# 8530)

    Glendale, Arizona

  • Galderma Investigational Site (# 8511)

    Phoenix, Arizona

  • Galderma Investigational Site (# 8009)

    Hot Springs, Arkansas

  • Galderma Investigational Site (# 8355)

    Rogers, Arkansas

  • Galderma Investigational Site (# 8456)

    Beverly Hills, California

  • Galderma Investigational site (8578)

    Cerritos, California

  • Galderma Investigational Site (# 8526)

    Clovis, California

  • Galderma Investigational Site (8577)

    Encinitas, California

  • Galderma Investigational Site (# 8224)

    Fremont, California

  • Galderma Investigational Site (# 8509)

    Fullerton, California

  • Galderma Investigational Site (# 8507)

    Huntington Beach, California

  • Galderma Investigational Site (# 8425)

    Newport Beach, California

  • Galderma Investigational Site (# 8052)

    Oceanside, California

  • Galderma Investigational Site (# 8528)

    Santa Ana, California

  • Galderma Investigational Site (# 8160)

    Santa Monica, California

  • Galderma Investigational Site (# 8443)

    Temecula, California

  • Galderma Investigational Site (8572)

    Colorado Springs, Colorado

  • Galderma Investigational Site (# 8510)

    Englewood, Colorado

  • Galderma Investigational Site (# 8370)

    Boynton Beach, Florida

  • Galderma Investigational Site (# 8543)

    Fort Lauderdale, Florida

  • Galderma Investigational Site (8143)

    Miami, Florida

  • Galderma Investigational site (8259)

    Miramar, Florida

  • Galderma Investigational Site (# 8522)

    North Miami Beach, Florida

  • Galderma Investigational Site (# 8531)

    Orange Park, Florida

  • Galderma Investigational Site (8502)

    Orlando, Florida

  • Galderma Investigational Site (#8213)

    Ormond Beach, Florida

  • Galderma Investigational Site (# 8529)

    Sanford, Florida

  • Galderma Investigational Site (# 8455)

    St. Petersburg, Florida

  • Galderma Investigational Site (# 8523)

    Tampa, Florida

  • Galderma Investigational Site (# 8126)

    West Palm Beach, Florida

  • Galderma Investigational Site (#8189)

    Snellville, Georgia

  • Galderma Investigational Site (8582)

    Idaho Falls, Idaho

  • Galderma Investigational Site (# 8367)

    Arlington Heights, Illinois

  • Galderma Investigational Site (8191)

    Chicago, Illinois

  • Galderma Investigational site (8571)

    Darien, Illinois

  • Galderma Investigational Site (8575)

    Oakbrook Terrace, Illinois

  • Galderma Investigational Site (# 8366)

    Plainfield, Indiana

  • Galderma Investigational Site (# 8532)

    Overland Park, Kansas

  • Galderma Investigational Site (# 8069)

    Louisville, Kentucky

Showing 40 of 124 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.